We’re sure that most readers of Points are already familiar with Sasha Shulgin and are aware of his passing on June 2. But the death of the man responsible for popularizing MDMA in the United States cannot go unremarked upon, especially as the slew of related news reports are bringing up important questions about the drug’s therapeutic use.
